跳至主要内容
临床试验/KCT0004809
KCT0004809招募中未知

Effects of consumption of HMR-foods on blood glucose

Chonbuk National University0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 70(Year)(—)
性别
All

入选标准

  • 1) Those who are between 19 and 70 years old at the time of screening test
  • 2) Persons with a BMI of 18.5 kg / m² or more and less than 35 kg / m²
  • 3) Those whose blood glucose level meets one of the following criteria
  • (1) Healthy adults: those with fasting and postprandial blood sugar in the normal range (less than 100 mg / dl fasting glucose, less than 140 mg / dl blood glucose 2 hours oral glucose test)
  • (2) pre-diabetic adults : 100-125 mg / dL of fasting blood glucose or 140-199 mg / dl of blood sugar for 2 hours of oral glucose tolerance test
  • 4) After hearing and fully understanding the detailed description of this human study, the person who voluntarily decides to participate and agrees to follow the instructions.

排除标准

  • 1) Those who have taken drugs that may affect blood glucose, such as hypoglycemic agents, diabetes treatments, obesity treatments, and lipid lowering agents, within 3 months from the screening test date
  • 2) Patients diagnosed with type 1 or type 2 diabetes
  • 3) have or suspected hereditary hyperlipidemia
  • 4) Those with fasting triglyceride levels of 200 mg / dl or more at the screening test
  • 5) Person who has clinically significant acute or chronic cardiocerebrovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal system, inflammatory and blood, neoplastic, gastrointestinal diseases, etc.
  • 6) Gastrointestinal disorders that may affect the absorption of human trial food or anyone with a history of gastrointestinal surgery (except for simple appendectomy or hernia surgery)
  • 7) Person who shows the following result in laboratory examination
  • ? AST, ALT> 3 times upper limit of normal range
  • ? Serum creatinine> 2.0 mg / dl
  • 8) Patients with systolic blood pressure of 160 mmHg or diastolic blood pressure of 100 mmHg or more (but those who are stably controlling blood pressure through medication can participate)
  • 9) Persons with a history of hypersensitivity or clinically significant hypersensitivity reactions to human trial food
  • 10) Those who have continuously taken dietary supplements (L-arabinose, guava leaf extract, etc.) or dietary supplements that may affect the results of this study within 2 weeks prior to the screening test
  • 11) Participants in other clinical trials within 3 months before the screening test
  • 12) have or suspect a history of alcoholism or drug abuse
  • 13) A person deemed unsuitable for participation in a clinical trial due to laboratory test results or other reasons

研究者

发起方
Chonbuk National University

相似试验